From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers—A Multidisciplinary Perspective
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers—A Multidisciplinary Perspective
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 8, Pages 2105
Publisher
MDPI AG
Online
2020-07-30
DOI
10.3390/cancers12082105
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High PD-L1 expression in gastric cancer (GC) patients and correlation with molecular features
- (2020) Xiaoqiao Liu et al. PATHOLOGY RESEARCH AND PRACTICE
- VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2-Study
- (2020) Elizabeth Smyth et al. Frontiers in Oncology
- Engineering Targeting Materials for Therapeutic Cancer Vaccines
- (2020) Priscilla S. Briquez et al. Frontiers in Bioengineering and Biotechnology
- ASO Author Reflections: Gastric Cancer Staging: More than Just TNM?
- (2020) Jakub Chmelo et al. ANNALS OF SURGICAL ONCOLOGY
- Optimization of perioperative approaches for advanced and late stages of gastric cancer: clinical proposal based on literature evidence, personal experience, and ongoing trials and research
- (2020) Maneesh Kumarsing Beeharry et al. World Journal of Surgical Oncology
- A Modified ypTNM Staging System–Development and External Validation of a Nomogram Predicting the Overall Survival of Gastric Cancer Patients Received Neoadjuvant Chemotherapy
- (2020) Ziyu Li et al. Cancer Management and Research
- Recent Developments of Systemic Chemotherapy for Gastric Cancer
- (2020) Hiroyuki Arai et al. Cancers
- Tumor Mutational Burden Determined by Panel Sequencing Predicts Survival After Immunotherapy in Patients With Advanced Gastric Cancer
- (2020) Jinchul Kim et al. Frontiers in Oncology
- Differential microRNA expression profiles associated with microsatellite status reveal possible epigenetic regulation of microsatellite instability in gastric adenocarcinoma
- (2020) Xiaofei Qu et al. Annals of Translational Medicine
- TGFB2 serves as a link between epithelial-mesenchymal transition and tumor mutation burden in gastric cancer
- (2020) BoWen Yang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Identification of miR-375 as a potential prognostic biomarker for esophageal squamous cell cancer: A bioinformatics analysis based on TCGA and meta-analysis
- (2019) He-San Luo et al. PATHOLOGY RESEARCH AND PRACTICE
- Exosomes in gastric cancer: roles, mechanisms, and applications
- (2019) Min Fu et al. Molecular Cancer
- Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2019) Charles S Fuchs et al. LANCET ONCOLOGY
- Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma
- (2019) Nobuhide Higashino et al. LABORATORY INVESTIGATION
- Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer
- (2019) Jiang Lv et al. Journal of Hematology & Oncology
- An open-label, phase II basket study of olaparib and durvalumab (MEDIOLA): Results in patients with relapsed gastric cancer.
- (2019) Yung-Jue Bang et al. JOURNAL OF CLINICAL ONCOLOGY
- KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancer
- (2019) Yung-Jue Bang et al. Future Oncology
- Targeting the Tumor Microenvironment in Radiation Oncology: Proceedings from the 2018 ASTRO–AACR Research Workshop
- (2019) Heather M. McGee et al. CLINICAL CANCER RESEARCH
- Comparison between clinical significance of serum CXCL-8 and classical tumor markers in oesophageal cancer (OC) patients
- (2019) Marta Łukaszewicz-Zając et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Hereditary gastric cancer: what’s new? Update 2013–2018
- (2019) Rachel S. van der Post et al. Familial Cancer
- Molecular carcinogenesis of gastric cancer: Lauren classification, mucin phenotype expression, and cancer stem cells
- (2019) Naohide Oue et al. International Journal of Clinical Oncology
- Perioperative atezolizumab in combination with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma: DANTE, a randomized, open-label phase II trial of the German Gastric Group of the AIO and the SAKK.
- (2019) Salah-Eddin Al-Batran et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase Ib study of IMU-131 HER2/neu peptide vaccine plus chemotherapy in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction.
- (2019) Yee Chao et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432
- (2019) F Wang et al. ANNALS OF ONCOLOGY
- Pembrolizumab with or without chemotherapy versus chemotherapy for advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The phase III KEYNOTE-062 study.
- (2019) Josep Tabernero et al. JOURNAL OF CLINICAL ONCOLOGY
- Regulatory T cells and M2 macrophages present diverse prognostic value in gastric cancer patients with different clinicopathologic characteristics and chemotherapy strategies
- (2019) Xu Liu et al. Journal of Translational Medicine
- Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial
- (2019) Ken Kato et al. LANCET ONCOLOGY
- Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma
- (2019) Ronan J. Kelly et al. CLINICAL CANCER RESEARCH
- Comparison of Phenotypes and Risk Factors for Esophageal Adenocarcinoma at Present vs Prior Decades
- (2019) Tarek Sawas et al. Clinical Gastroenterology and Hepatology
- Systematic Review with Meta-analysis: Association of Helicobacter pylori Infection with Esophageal Cancer
- (2019) Huiqin Gao et al. Gastroenterology Research and Practice
- The immune landscape of esophageal cancer
- (2019) Tu-Xiong Huang et al. Cancer Communications
- Specific DNA methylation markers in the diagnosis and prognosis of esophageal cancer
- (2019) DaPeng Li et al. Aging-US
- EGFRvIII: An Oncogene with Ambiguous Role
- (2019) Adrianna Rutkowska et al. Journal of Oncology
- The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017
- (2019) Arash Etemadi et al. Lancet Gastroenterology & Hepatology
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Antitumor activity of pan-HER inhibitors in HER2-positive gastric cancer
- (2018) Takahiro Yoshioka et al. CANCER SCIENCE
- Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: Current status and future perspectives
- (2018) Julien Taieb et al. CANCER TREATMENT REVIEWS
- Epidemiology of Esophageal Squamous Cell Carcinoma
- (2018) Christian C. Abnet et al. GASTROENTEROLOGY
- The Epidemiology of Esophageal Adenocarcinoma
- (2018) Helen G. Coleman et al. GASTROENTEROLOGY
- pSTAT3 Levels Have Divergent Expression Patterns and Associations with Survival in Squamous Cell Carcinoma and Adenocarcinoma of the Oesophagus
- (2018) Katie O’ Sullivan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis
- (2018) Han S. Kim et al. JOURNAL OF SURGICAL ONCOLOGY
- Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
- (2018) Kohei Shitara et al. LANCET
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Folate receptor 1 (FOLR1) targeted chimeric antigen receptor (CAR) T cells for the treatment of gastric cancer
- (2018) Minsung Kim et al. PLoS One
- Personalized vaccines for cancer immunotherapy
- (2018) Ugur Sahin et al. SCIENCE
- EphA2 chimeric antigen receptor-modified T cells for the immunotherapy of esophageal squamous cell carcinoma
- (2018) Hui Shi et al. Journal of Thoracic Disease
- Gastric cancer: epidemiology, prevention, classification, and treatment
- (2018) Robert Sitarz et al. Cancer Management and Research
- RHBDF2-Regulated Growth Factor Signaling in a Rare Human Disease, Tylosis With Esophageal Cancer: What Can We Learn From Murine Models?
- (2018) Vishnu Hosur et al. Frontiers in Genetics
- Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
- (2018) Charles S. Fuchs et al. JAMA Oncology
- Palmoplantar Hyperkeratosis and Strong Family History of Esophageal Cancer: Tylosis or Not?
- (2018) Hussein Abidali et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300
- (2018) Y -J Bang et al. ANNALS OF ONCOLOGY
- Oral Alpha, Beta, and Gamma HPV Types and Risk of Incident Esophageal Cancer
- (2018) Ilir Agalliu et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer
- (2018) Yelena Y. Janjigian et al. JOURNAL OF CLINICAL ONCOLOGY
- Association of IL10 gene promoter polymorphisms with risks of gastric cancer and atrophic gastritis
- (2018) Sa Liu et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer
- (2018) Daniela Cornelia Lazăr et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2
- (2018) Yuko Kitagawa et al. Esophagus
- Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1
- (2018) Yuko Kitagawa et al. Esophagus
- Adenocarcinoma of the esophagogastric junction and its background mucosal pathology: A comparative analysis according to Siewert classification in a Japanese cohort
- (2018) Masayuki Urabe et al. Cancer Medicine
- Prognostic value of immunohistochemical factors in esophageal small cell carcinoma (ESCC): analysis of clinicopathologic features of 73 patients
- (2018) Yigong Zhang et al. Journal of Thoracic Disease
- Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4)
- (2018) N Boku et al. ANNALS OF ONCOLOGY
- Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer
- (2018) Funda Meric-Bernstam et al. CLINICAL CANCER RESEARCH
- The Fast Real-time Assessment of Combination Therapies in Immuno-ONcology (FRACTION) program: innovative, high-throughput clinical screening of immunotherapies
- (2018) Katy L. Simonsen et al. EUROPEAN JOURNAL OF CANCER
- From Tumor Immunology to Immunotherapy in Gastric and Esophageal Cancer
- (2018) David Vrána et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Identification of miRNA profiling in prediction of tumor recurrence and progress and bioinformatics analysis for patients with primary esophageal cancer: Study based on TCGA database
- (2018) Fangyao Chen et al. PATHOLOGY RESEARCH AND PRACTICE
- Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus
- (2018) Manish A. Shah et al. JAMA Oncology
- Candidate susceptibility variants for esophageal squamous cell carcinoma
- (2017) Iikki Donner et al. GENES CHROMOSOMES & CANCER
- Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression
- (2017) Lei Pan et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The relevance and implications of signet-ring cell adenocarcinoma of the oesophagus
- (2017) Christopher William Bleaney et al. JOURNAL OF CLINICAL PATHOLOGY
- Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Yoon-Koo Kang et al. LANCET
- Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2017) Yung-Jue Bang et al. LANCET ONCOLOGY
- Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial
- (2017) Toshihiro Kudo et al. LANCET ONCOLOGY
- Clinicopathological factors associated with HER2-positive gastric cancer
- (2017) Hong-Bo Wang et al. MEDICINE
- Combined immune checkpoint blockade as a therapeutic strategy for BRCA1 -mutated breast cancer
- (2017) Emma Nolan et al. Science Translational Medicine
- Gastric cancer-derived heat shock protein-gp96 peptide complex enhances dendritic cell activation
- (2017) Wen-Wen Lu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis
- (2017) Haiyang Zhang et al. Nature Communications
- M2 macrophages are more resistant than M1 macrophages following radiation therapy in the context of glioblastoma
- (2017) Marine M. Leblond et al. Oncotarget
- Targeted therapies for gastric cancer: failures and hopes from clinical trials
- (2017) Maria Apicella et al. Oncotarget
- Phase II Trial of Adjuvant Immunotherapy with Autologous Tumor-derived Gp96 Vaccination in Patients with Gastric Cancer
- (2017) Kecheng Zhang et al. Journal of Cancer
- Clinical value of integrated-signature miRNAs in esophageal cancer
- (2017) Heng-Chao Zhang et al. Cancer Medicine
- PD-L1 and gastric cancer prognosis: A systematic review and meta-analysis
- (2017) Lihu Gu et al. PLoS One
- Síndrome de Li-Fraumeni
- (2016) Carlos Andrés Ossa et al. Biomedica
- MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinoma
- (2016) Daniel V. T. Catenacci et al. CANCER
- Bifunctional αHER2/CD3 RNA-engineered CART-like human T cells specifically eliminate HER2+ gastric cancer
- (2016) Feifei Luo et al. CELL RESEARCH
- Translating gastric cancer genomics into targeted therapies
- (2016) Yvonne L.E. Ang et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy
- (2016) Riccardo Giampieri et al. Gastric Cancer
- Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma
- (2016) Elizabeth D Thompson et al. GUT
- Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
- (2016) Christina Pfirschke et al. IMMUNITY
- The role of cancer-associated fibroblasts in esophageal cancer
- (2016) Jiangfeng Wang et al. Journal of Translational Medicine
- Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
- (2016) Kei Muro et al. LANCET ONCOLOGY
- Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort
- (2016) M Apicella et al. ONCOGENE
- Personalized medicine in gastric cancer: Where are we and where are we going?
- (2016) Alexandre A Jácome WORLD JOURNAL OF GASTROENTEROLOGY
- Human papillomavirus and gastrointestinal cancer: A review
- (2016) Dania Bucchi et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Current and emerging therapies in unresectable and recurrent gastric cancer
- (2016) Erin Jou et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Importance of the type I insulin-like growth factor receptor in HER2, FGFR2 and MET-unamplified gastric cancer with and without Ras pathway activation
- (2016) Marina Saisana et al. Oncotarget
- Tumour staging of oesophageal cancer in the Swedish Cancer Registry: A nationwide validation study
- (2015) Nele Brusselaers et al. ACTA ONCOLOGICA
- ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes
- (2015) Sapna Syngal et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Familial gastric cancer: genetic susceptibility, pathology, and implications for management
- (2015) Carla Oliveira et al. LANCET ONCOLOGY
- Paired exome analysis of Barrett's esophagus and adenocarcinoma
- (2015) Matthew D Stachler et al. NATURE GENETICS
- Whole-genome sequencing provides new insights into the clonal architecture of Barrett's esophagus and esophageal adenocarcinoma
- (2015) Caryn S Ross-Innes et al. NATURE GENETICS
- Combination cancer immunotherapies tailored to the tumour microenvironment
- (2015) Mark J. Smyth et al. Nature Reviews Clinical Oncology
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinicopathological Variation of Lauren Classification in Gastric Cancer
- (2015) Yun-Chi Chen et al. PATHOLOGY & ONCOLOGY RESEARCH
- The development of the TNM classification of gastric cancer
- (2015) Christian Wittekind PATHOLOGY INTERNATIONAL
- Hereditary Gastric Cancer Syndromes
- (2015) Hugh Colvin et al. Surgical Oncology Clinics of North America
- From reflux esophagitis to Barrett’s esophagus and esophageal adenocarcinoma
- (2015) Rui-Hua Wang WORLD JOURNAL OF GASTROENTEROLOGY
- Targeted therapy for advanced gastric cancer: A review of current status and future prospects
- (2015) Ozkan Kanat et al. World Journal of Gastrointestinal Oncology
- Review article: bacteria and pathogenesis of disease in the upper gastrointestinal tract - beyond the era ofHelicobacter pylori
- (2014) M. M. Walker et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Adoptive Immunotherapy for Cancer or Viruses
- (2014) Marcela V. Maus et al. Annual Review of Immunology
- HER2-positive gastric cancer with concomitant MET and/or EGFR overexpression: A distinct subset of patients for dual inhibition therapy
- (2014) Sang Yun Ha et al. INTERNATIONAL JOURNAL OF CANCER
- Phase I clinical trial of peptide vaccination with URLC10 and VEGFR1 epitope peptides in patients with advanced gastric cancer
- (2014) YOSHIE HIGASHIHARA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells
- (2014) Julio Gomez-Rodriguez et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Progression of Barrett oesophagus: role of endoscopic and histological predictors
- (2014) Rajeswari Anaparthy et al. Nature Reviews Gastroenterology & Hepatology
- Treatment options in patients with metastatic gastric cancer: Current status and future perspectives
- (2014) Ahmet Bilici WORLD JOURNAL OF GASTROENTEROLOGY
- MiRNA as potential biomarkers and therapeutic targets for gastric cancer
- (2014) Vivian Yvonne Shin WORLD JOURNAL OF GASTROENTEROLOGY
- Oxidative DNA damage in human esophageal cancer: clinicopathological analysis of 8-hydroxydeoxyguanosine and its repair enzyme
- (2013) N. Kubo et al. DISEASES OF THE ESOPHAGUS
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
- (2013) Tom Waddell et al. LANCET ONCOLOGY
- Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial
- (2013) Florian Lordick et al. LANCET ONCOLOGY
- Prognostic significance of BRCA1 expression in gastric cancer
- (2013) Wenjiao Chen et al. MEDICAL ONCOLOGY
- Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity
- (2013) Austin M Dulak et al. NATURE GENETICS
- Helicobacter pyloriinfection and esophageal cancer risk: An updated meta-analysis
- (2013) Fa-Jun Xie WORLD JOURNAL OF GASTROENTEROLOGY
- Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation
- (2013) K Kono et al. Cell Death & Disease
- Molecular targeted therapy for advanced gastric cancer
- (2013) Jong Gwang Kim KOREAN JOURNAL OF INTERNAL MEDICINE
- Efficient induction of specific cytotoxic T lymphocytes against gastric adenocarcinoma by a survivin peptide
- (2012) Yi Gang et al. Biochemistry and Cell Biology
- Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancer
- (2012) TORU MASUZAWA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Cancers of unknown primary origin: current perspectives and future therapeutic strategies
- (2012) Giulia Stella et al. Journal of Translational Medicine
- Comparative Genomic Analysis of Esophageal Adenocarcinoma and Squamous Cell Carcinoma
- (2012) Nishant Agrawal et al. Cancer Discovery
- Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
- (2011) Atsushi Ohtsu et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of interleukin 1 beta in esophageal squamous cell carcinoma
- (2011) Miao-Fen Chen et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Combination immunotherapy and active-specific tumor cell vaccination augments anti-cancer immunity in a mouse model of gastric cancer
- (2011) Natasja K van den Engel et al. Journal of Translational Medicine
- Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers
- (2011) Kenji Tomizawa et al. LUNG CANCER
- Identification of new aberrantly expressed miRNAs in intestinal-type gastric cancer and its clinical significance
- (2011) Wei Wu ONCOLOGY REPORTS
- Genome-Wide Catalogue of Chromosomal Aberrations in Barrett's Esophagus and Esophageal Adenocarcinoma: A High-Density Single Nucleotide Polymorphism Array Analysis
- (2010) J. Gu et al. Cancer Prevention Research
- Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity
- (2010) S. Kreiter et al. CANCER RESEARCH
- Advanced gastric cancer – Slow but steady progress
- (2010) Derek G. Power et al. CANCER TREATMENT REVIEWS
- NF-κB targets miR-16 and miR-21 in gastric cancer: involvement of prostaglandin E receptors
- (2010) Vivian Y. Shin et al. CARCINOGENESIS
- H. pylori Infection Is a Key Risk Factor for Proximal Gastric Cancer
- (2010) Jan Bornschein et al. DIGESTIVE DISEASES AND SCIENCES
- Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: epidemiology, clinical findings, and prevention
- (2010) Masaru Morita et al. International Journal of Clinical Oncology
- Messenger RNA-based Vaccines With Dual Activity Induce Balanced TLR-7 Dependent Adaptive Immune Responses and Provide Antitumor Activity
- (2010) Mariola Fotin-Mleczek et al. JOURNAL OF IMMUNOTHERAPY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Let-7 MicroRNA Family Is Selectively Secreted into the Extracellular Environment via Exosomes in a Metastatic Gastric Cancer Cell Line
- (2010) Keiichi Ohshima et al. PLoS One
- The Role of Regulatory T Cells in Cancer
- (2010) Tai-You Ha Immune Network
- MicroRNAs: Novel regulators in the hallmarks of human cancer
- (2009) Kai Ruan et al. CANCER LETTERS
- Folate-targeted therapeutic and imaging agents for cancer
- (2009) Philip Stewart Low et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Down-regulated miR-9 and miR-433 in human gastric carcinoma
- (2009) Hongchun Luo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
- (2009) S. Ostrand-Rosenberg et al. JOURNAL OF IMMUNOLOGY
- Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients
- (2009) Benjamin Weide et al. JOURNAL OF IMMUNOTHERAPY
- Decreased Expression of MicroRNA-143 and -145 in Human Gastric Cancers
- (2009) Takeshi Takagi et al. ONCOLOGY
- Oxidative Stress and Oxidative Damage in Carcinogenesis
- (2009) James E. Klaunig et al. TOXICOLOGIC PATHOLOGY
- Molecular cancer therapy: Can our expectation be MET?
- (2008) Cristina Migliore et al. EUROPEAN JOURNAL OF CANCER
- The Essential Role of Fibroblasts in Esophageal Squamous Cell Carcinoma–Induced Angiogenesis
- (2008) Kazuhiro Noma et al. GASTROENTEROLOGY
- Results of the First Phase I/II Clinical Vaccination Trial With Direct Injection of mRNA
- (2008) Benjamin Weide et al. JOURNAL OF IMMUNOTHERAPY
- Potential Role of NF-κB in Esophageal Adenocarcinoma: As an Emerging Molecular Target
- (2008) Mohamed M.M. Abdel-Latif et al. JOURNAL OF SURGICAL RESEARCH
- miR-21 plays a pivotal role in gastric cancer pathogenesis and progression
- (2008) Zhiyu Zhang et al. LABORATORY INVESTIGATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started